• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC COVIDIEN PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC COVIDIEN PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hematoma (1884)
Event Type  Injury  
Manufacturer Narrative
Citation: brendan d.Killory, kent j.Kilbourn, martin ollenschleger."a novel use of direct platelet application during surgery for clopidogrel-associated intracerebral hemorrhage" world neurosurg.(2015) 84, 6:2078.E1-2078.E4.Http://dx.Doi.Org/10.1016/j.Wneu.2015.08.016 the device will not be returned for evaluation as it was implanted in the patient.Based on the reported information, there did not appear to have been any defect of the device during use.The event occurred in the patient post procedure and its cause was unknown.
 
Event Description
Medtronic received information through literature review that this patient experienced a large right temporal intracerebral hematoma 14 days after implant of two pipeline devices.It was reported that a this patient presented with an intradural right vertebral artery dissection with a ruptured 6-mm pseudoaneurysm.The patient was started on aspirin and clopidogrel and the vessel was reconstructed with 2 pipeline embolization devices.On postbleed day number 14, she became obtunded with a blown right pupil; computed tomography of the head demonstrated a large right temporal intracerebral hematoma.The patient was taken emergently to the operating room for evacuation of the clot.Intraoperatively, satisfactory control of bleeding was not achieved despite transfusing several units of platelets intravenously.Ultimately, a mixture of floseal and platelets applied directly to the hematoma wall allowed prompt hemostasis.At 3 months the patient was doing extremely well clinically and angiography demonstrated occlusion of the aneurysm.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MEDTRONIC COVIDIEN
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MEDTRONIC COVIDIEN
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9498373700
MDR Report Key5773801
MDR Text Key48918304
Report Number2029214-2016-00513
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/08/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/08/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
-
-